Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Announcements

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism

Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism

Nov 2, 2023
Extended-Release Calcifediol Overcomes Impact of Low eGFR on Vitamin D Metabolism

Extended-Release Calcifediol Overcomes Impact of Low eGFR on Vitamin D Metabolism

Nov 2, 2023
ASN Kidney Week 2023 Poster Presentation - Control of Secondary Hyperparathyroidism with Extended-release Calcifediol is Associated with Slower CKD Progression

ASN Kidney Week 2023 Poster Presentation - Control of Secondary Hyperparathyroidism with Extended-release Calcifediol is Associated with Slower CKD Progression

Nov 2, 2023

OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

May 9, 2022
ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD)

ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD)

Nov 5, 2021

Introduction of Scarlet Health™ In-Home Diagnostic Service

Jan 13, 2021

NFL Profiles BioReference During Sunday Games

Jan 5, 2021
Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects

Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects

Oct 28, 2020
Presentation by Dr. Cheri Deal at ENDO Online 2020

Presentation by Dr. Cheri Deal at ENDO Online 2020

Jun 8, 2020

Replay of the Evercore ISI COVID Dx Webinar with OPKO and BioReference Senior Leadership

May 27, 2020
RSS
  • 1
  • 2
  • Next »

OPKO HEALTH, INC.
4400 Biscayne Boulevard
Miami, FL 33137

305-575-4100
contact@opko.com

© 2023 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of Use Sitemap